STERIS to consolidate chemistry operations in North Carolina with $55M-$70M in charges

STERIS announced on August 5, 2026, that it will consolidate formulated-chemistry manufacturing and distribution at a new North Carolina Center of Excellence and expects to close facilities in St. Louis, Missouri, and Plymouth, Minnesota. The plan is expected to generate $55 million to $70 million in pre-tax restructuring charges, including $40 million to $50 million in cash costs, through fiscal 2030; STERIS also raised fiscal 2027 capital expenditure expectations to about $450 million from $375 million and lowered free cash flow guidance to about $800 million from $850 million.